Publications Search - Abstract View
||Human herpesvirus 8 seroprevalence among prostate cancer case patients and control subjects.
||Jenkins FJ, Hayes RB, Jackson A, Pizza G, Mbisa G, Whitby D, Goedert JJ
||J Infect Dis
||2007 Jul 15
||OEEB, EBP, IIB
||To investigate a possible association between human herpesvirus 8 (HHV-8) and prostate cancer, we evaluated HHV-8 seroprevalence in 2 case-control studies. HHV-8 antibodies were detected by immunofluorescence with cells expressing lytic viral proteins and by enzyme immunoassays with recombinant viral structural protein (K8.1) and latent protein (latency-associated nuclear antigen-1; open reading frame 73), respectively. HHV-8 seroprevalence tended to be lower in patients with prostate cancer than in control subjects, but there was no significant difference in either study. These data imply that HHV-8 is not a major prevalent cause of prostate cancer.